Jh. Pauwels et al., STUDY OF THE BRONCHODILATING EFFECT OF 3 DOSES OF NEBULIZED OXITROPIUM BROMIDE IN ASTHMATIC PRESCHOOL-CHILDREN USING THE FORCED OSCILLATIONTECHNIQUE, European journal of pediatrics, 156(4), 1997, pp. 329-332
The aim of this study was to evaluate the bronchodilating capacity of
nebulized oxitropium bromide (OB) in preschool asthmatic children and
to determine an appropriate dose for usage in this age group. The tria
l enrolled 20 patients with moderate to severe stable asthma aged betw
een 3.2 and 6.2 years (mean 4.7). Applying a placebo controlled, doubl
e-blind design, the effect of placebo was compared with three differen
t doses of OB (375, 750 and 1500 mu g) and with 400 mu g fenoterol. Th
e three different doses of OB resulted in a highly significant broncho
dilation within 15 min after administration. The observed bronchodilat
ion was comparable between the three doses during the first 2 h. Howev
er, after 4 h the lowest dose was significantly less powerful than the
highest dose. Compared to the additional bronchodilation induced by f
enoterol, no difference was found with the degree of bronchodilation o
f OB which occurred during the first 2 h. Furthermore, after 4 h only
the lowest dose of OB was significantly less powerful than fenoterol a
ssessed 10 min following a single 400 mu g dose. Conclusion Oxitropium
bromide is a potent and long-acting bronchodilator in preschool child
ren at a dose of 750 mu g and 1500 mu g. No side-effects were observed
. The exact duration of action remains uncertain, but even 4 h after i
nhaling 750 or 1500 mu g of OB no additive bronchodilation induced by
fenoterol could be observed.